Key result
Serum uric acid fails to predict LVEF or differentiate phenotypes in acute heart failure.
Why the study?
It was unclear whether serum uric acid acts as an independent predictor of LVEF or merely reflects cardiometabolic distress in AHF.
Does admission serum uric acid independently predict left ventricular ejection fraction in patients hospitalized with acute heart failure?
Cross-Sectional (n=306)
No
Does admission serum uric acid independently predict left ventricular ejection fraction in patients hospitalized with acute heart failure?
Odds Ratio: 0.995
p-value: p=0.973
Serum uric acid does not independently predict reduced ejection fraction in acute heart failure, suggesting it acts as a biomarker of cardiometabolic distress and diuretic use rather than a direct driver of myocardial dysfunction.
Does not support uric acid for LVEF prediction in acute HF; hypothesis-generating for its role as a comorbidity marker.
Background/Objectives: Acute heart failure (AHF) is a leading cause of global morbidity, necessitating the search for reliable biomarkers to guide risk stratification. While hyperuricemia is highly prevalent in heart failure patients and historically considered a potential “cardiotoxin”, contemporary evidence suggests that it may function as a surrogate biomarker for cardiometabolic distress rather than an independent driver of myocardial dysfunction. This study aimed to determine whether serum uric acid acts as an independent predictor of left ventricular ejection fraction (LVEF) in a high-risk cardiometabolic cohort. Methods: This retrospective, cross-sectional study analyzed 306 patients hospitalized for acute heart failure at a tertiary hospital in Timisoara, Romania. Data were analyzed using JASP (v0.96). Statistical methods included Shapiro–Wilk testing, Spearman’s rank-order correlation, and independent samples t-tests. Multivariable ordinary least squares linear regression and maximum likelihood logistic regression were employed to identify predictors of LVEF and diagnostic classification, adjusting for comorbidities and diuretic administration. Results: Hyperuricemia was present in 64.6% of the cohort. Multivariable linear regression demonstrated that while age, sex, and diuretic use significantly predicted LVEF variance, serum uric acid did not (p = 0.356). Furthermore, logistic regression confirmed uric acid possessed no diagnostic utility in differentiating heart failure phenotypes (OR = 0.995; p = 0.973). Conclusions: Serum uric acid is not an independent predictor of reduced ejection fraction in acute heart failure patients. Elevated uric acid appears to be a biochemical shadow of generalized metabolic distress, systemic congestion, and the pharmacokinetic effects of diuretic therapy rather than a pathological driver of contractile dysfunction.
No takes yet. Share an insight, caveat, or question.
Ibănescu et al. (2026) conducted a cross-sectional in Acute heart failure (n=306). Serum uric acid was evaluated on Diagnostic classification of non-HFrEF phenotype (OR 0.995, p=0.973). Serum uric acid did not independently predict left ventricular ejection fraction variance (p=0.356) or differentiate heart failure phenotypes (OR 0.995, p=0.973) in acute heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: